Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug- and Rifampicin-resistant Tuberculosis”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Large-scale testing (Phase 3)Looking for participantsNCT06441006
What this trial is testing

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco 400
Not applicableLooking for participantsNCT06590428
What this trial is testing

Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis

Who this might be right for
Rifampin-resistant TuberculosisDrug-resistant Tuberculosis
Albert Einstein College of Medicine 280
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Large-scale testing (Phase 3)Not Yet RecruitingNCT07268664
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

Who this might be right for
Rifampicin Resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Beijing Chest Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07170800
What this trial is testing

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Who this might be right for
TuberculosisMultidrug Resistant Pulmonary TuberculosisRifampicin-resistant Tuberculosis
WestVac Biopharma Co., Ltd. 60
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Large-scale testing (Phase 3)Not Yet RecruitingNCT07675954
What this trial is testing

A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis

Who this might be right for
Rifampicin-Resistant Tuberculosis
Seoul National University Hospital 294
Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Post-approval studies (Phase 4)Looking for participantsNCT05381194
What this trial is testing

BPaL(M) Regimen for the Treatment of MDR/RR-TB

Who this might be right for
Multidrug- and Rifampicin-resistant Tuberculosis
Asan Medical Center 80
Not applicableNot Yet RecruitingNCT07191834
What this trial is testing

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Who this might be right for
Rifampicin-resistant/Multidrug-resistant Pulmonary TuberculosisType 2 Diabetes Mellitus (T2DM)Pretomanid
Wuhan Pulmonary Hospital 60
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Not applicableLooking for participantsNCT05671718
What this trial is testing

Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment

Who this might be right for
Drug Resistant Tuberculosis
Johns Hopkins University 2,944
Not applicableStudy completedNCT04147676
What this trial is testing

Evaluation of Centralised TB Assay Solutions

Who this might be right for
TuberculosisDrug-resistant Tuberculosis
Foundation for Innovative New Diagnostics, Switzerland 1,050
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Next Page